Drug Trial Radar · NCT02617446
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure
Last checked: Nov 19, 2026Latest source record: May 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Dec 2015
Primary completion
Aug 14, 2018
Study completion Feb 6, 2019
Sponsor
- Lead sponsor
- Windtree TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 1, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the safety, tolerability and efficacy of two different doses of istaroxime, a new agent with lusitropic and inotropic activities that improves the cardiac contraction-relaxation cycle. The 2 doses of istaroxime (0.5 and 1.0 µg/kg/min) will be infused via i. v. for 24 hours in comparison with placebo, in treatment of Chinese and Italian patients with Acute Decompensated Heart Failure.
Conditions
- Acute Decompensated Heart Failure
Interventions
PlaceboDrug
IV of matching saline solution
IstaroximeDrug
IV infusion of 0.5 µg/kg/min or 1.0 µg/kg/min istaroxime
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in E/Ea RatioTime frame: 24 hours
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Fuwai Hospital Chinese Academy of Medical Sciences
Beijing, China
Beijing Chao Yang Hospital
Beijing, China
The 307th Hospital of Chinese People's Liberation Army
Beijing, China
Lanzhou University No.2 Hospital
Lanzhou, Gansu, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Jiangsu Province People's Hospital
Nanjing, Jiangsu, China
The General Hospital Of Shenyang Military Region
Shenyang, Liaoning, China
The First Affiliated Hospital Of Xi'an Jiaotong University
Xi'an, Shaanxi, China
University and Civil Hospital of Brescia
Brescia, Italy
University of Milano-Bicocca
Milan, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.